Haruko Takuwa Wakako Tsuji Fumiaki Yotsumoto
10.1016/j.ijscr.2018.10.008
Int J Surg Case Rep
2018;52:125-131.
anti-her2 therapy clinical complete response metastatic breast cancer multidisciplinary therapy termination of therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/30343261/
PMC6198101
30343261
Patients who achieved long-term clinical complete response and subsequently terminated multidisciplinary and anti-HER2 therapy for metastatic breast cancer: A case series
2018